scispace - formally typeset
F

Flavia Cassiola

Researcher at Boston Children's Hospital

Publications -  6
Citations -  1821

Flavia Cassiola is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Sunitinib & Angiogenesis. The author has an hindex of 6, co-authored 6 publications receiving 1679 citations.

Papers
More filters
Journal ArticleDOI

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

TL;DR: Left ventricular dysfunction might be due, in part, to direct cardiomyocyte toxicity, exacerbated by hypertension, and patients treated with sunitinib should be closely monitored for hypertension and LVEF reduction, especially those with a history of coronary artery disease or cardiac risk factors.
Journal ArticleDOI

Platelets actively sequester angiogenesis regulators

TL;DR: It is shown that accumulation of angiogenesis regulators in platelets of animals bearing malignant tumors exceeds significantly their concentration in plasma or serum, as well as their levels in Platelets from non-tumor-bearing animals.
Journal ArticleDOI

Nanomagnetic actuation of receptor-mediated signal transduction.

TL;DR: A magnetic nanotechnology that activates a biochemical signalling mechanism normally switched on by binding of multivalent chemical ligands, and may represent a new actuator mechanism for cell-based microtechnologies and man-machine interfaces.
Journal ArticleDOI

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

TL;DR: Lodamin is an oral nontoxic antiangiogenic drug that can be chronically administered for cancer therapy or metastasis prevention and first reaches the liver, making it especially efficient in preventing the development of liver metastasis in mice.
Journal ArticleDOI

Cellular mechanism of oral absorption of solidified polymer micelles

TL;DR: Monomethoxy polyethylene glycol-poly lactic acid micelles are developed as a drug nanocarrier, and the mechanism of uptake across intestinal cells is studied, finding that mPEG-PLA nanoparticle endocytosis is mediated by clathrin in an energy-dependent manner, and that the low-density lipoprotein receptor is involved.